Pharmaceutical News

Oxford BioTherapeutics Partners with Bristol Myers Squibb to Develop New Cancer Treatments

/ April 11, 2026

Oxford BioTherapeutics (OBT) has started a long-term partnership with Bristol Myers Squibb (BMS) to create and develop new cancer therapies […]

/ April 10, 2026

Artificial Intelligence (AI) is being talked about as the future of drug development, with promises of faster, smarter, and more

/ April 8, 2026

A recent study has found that combining an antidepressant with a small molecule drug called Caplyta (lumateperone) can significantly improve

/ April 7, 2026

BioNTech, the German biotech company known for its COVID-19 vaccine, has announced plans to close its Singapore manufacturing plant and

/ April 6, 2026

A second weight-loss pill, called Foundayo (orforglipron), has just been approved in the U.S. by the FDA. This new medication

/ April 5, 2026

A new medication called elegrobart, developed by Viridian Therapeutics, has shown encouraging results in a large clinical trial for people

/ April 4, 2026

Pharmaceutical companies now have more ways than ever to communicate with doctors and other healthcare providers (HCPs). These include traditional

/ April 3, 2026

Two large clinical trials, called OBERON and TITANIA, have shown that a new medication called tozorakimab significantly reduces the number

/ April 1, 2026

Hello everyone! I want to share some important updates in the pharmaceutical world that have happened recently. These developments could

/ March 31, 2026

Gilead Sciences, a leading pharmaceutical company, has just made a big investment in a new type of treatment for immune